Find out if you might be eligible.
Transcranial Magnetic Stimulation (TMS) is a well-recognised, non-invasive treatment for depression.
TMS is delivered by a magnetic coil placed lightly against the scalp. The coil produces magnetic fields which induce electrical activity in adjacent areas of the brain.
The location and frequency of the magnetic pulses can be varied to either stimulate or subdue targeted areas, such as those regions involved in the regulation of mood.
TMS has been used to treat thousands of patients worldwide. After 30 years of extensive study, no long-term side effects have been identified.
TMS may involve side-effects during treatment, but these are almost always mild and brief and only rarely lead to stopping treatment. Most common are passing fatigue and mild scalp discomfort or headache.
Some specific conditions may make you not suitable for TMS treatment. Our psychiatrists undertake initial assessment to confirm your suitability for TMS treatment.
Around 50% of patients with depression that has not improved with medication will have a clinically meaningful response to TMS. Around one third of these patients will achieve full remission of their symptoms.
However, TMS, like other depression treatments, is not a permanent cure. The average length of response is around a year. When necessary, patients may return for another treatment or receive regular booster sessions to maintain their improvement.
Every patient is different and the only way to decide the optimal treatment is through a proper assessment. TMS may be right for you if:
TMS is likely not for you if you have a metal implant, such as a pacemaker or defibrillator.
TMS treatment for depression at NeuroCentrix clinics typically consists of 20 to 30 sessions delivered as an outpatient over 3 to 6 weeks.
Treatment costs may be met in full for serving military, DVA, and WorkCover patients upon successful application.
Private treatment is available at $185 per session. Medicare does not currently rebate TMS treatment, however, some private health funds cover the cost of outpatient TMS.